Phase 1 Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of F-652 with a Single Dose in Healthy Male Volunteers

Trial Profile

Phase 1 Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of F-652 with a Single Dose in Healthy Male Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 08 Jun 2016

At a glance

  • Drugs F 652 (Primary)
  • Indications Alcoholic hepatitis
  • Focus Adverse reactions; First in man
  • Sponsors Generon (Shanghai) Corporation
  • Most Recent Events

    • 04 May 2015 Positive results published in a Generon (Shanghai) Corporation media release.
    • 04 May 2015 Status changed from not yet recruiting to completed, as reported in a Generon (Shanghai) Corporation media release.
    • 07 Jan 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top